Can your own blood cure your hives? new trial investigates
NCT ID NCT07486583
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether injecting a patient's own blood (autologous whole blood therapy) can help control chronic hives that don't respond to high-dose antihistamines. 40 adults with chronic idiopathic urticaria will receive either the blood injections plus antihistamines or antihistamines alone for 8 weeks. The main goal is to see if the blood therapy reduces hive activity scores.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous whole blood therapy (injections of the patient's own blood) plus desloratadine (antihistamine)
- What this could lead to
- If it works, this could offer a new treatment option for people with chronic hives that don't respond to standard antihistamines.
- What could go wrong
- This is a small, early-stage trial with only 40 people. The treatment is experimental and may not work better than antihistamines alone. There is also a risk of injection site reactions or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC IDIOPATHIC URTICARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine, Cairo university
Cairo, Cairo Governorate, 11553, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.